Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 5, 1998, Pages 567-570

  Rath, P M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; CONTROLLED STUDY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0031971963     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.5.567     Document Type: Article

References (10)

1. Bennett, J. E. (1995). Aspergillus species. In Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2306-11. Churchill Livingstone, New York.
2. Dermoumi, H. (1994). In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole and amphotericin B. Chemotherapy 40, 92-8.
3. Espinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C., Fothergill, A. et al. (1997). Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. Journal of Clinical Microbiology 35, 139-43.
4. Moore, C. B., Law, D. & Denning, D. W. (1993). In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp. Journal of Antimicrobial Chemotherapy 32, 831-6.
5. Schmitt, H. J., Edwards, F., Andrade, J., Niki, Y. & Armstrong, D. (1992). Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis. Chemotherapy 38, 118-26.
6. Pfaller, M. A., Rex, J. H. & Rinaldi, M. G. (1997). Antifungal susceptibility testing: technical advances and potential clinical applications. Clinical Infectious Diseases 24, 776-84.
7. Espinel-Ingroff, A. & Pfaller, M. A. (1995). Antifungal agents and susceptibility testing. In Manual of Clinical Microbiology, 6th edn (Murray, P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 1405-14. ASM Press, Washington, DC.
8. Otčenášek, M. (1992). In vitro activity of antifungal agents against clinical isolates of aspergilli. International Journal of Medical Microbiology, Virology, Parasitology and Infectious Diseases 277, 100-5.
9. Denning, D. W., Hanson, L. H., Perlman, A. M. & Stevens, D. A. (1992). In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagnostic Microbiology and Infectious Diseases 15, 21-34.
10. Denning, D, W., Venkateswarlu, K., Oakley, K. L, Anderson, M. J., Manning, N. J., Stevens, D. A. et al. (1997). Itraconazole resistance in Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 41, 1364-8.